Thursday, Oct 22, 2026

"bristol-myers-squibb"

Sun Pharma settles patent dispute with US Celgene Corporation

In addition, the license will also allow Sun Pharma to manufacture and sell an unlimited quantity of generic lenalidomide capsules in the US beginning January 31, 2026.

Latest News

Delhi Police summons three CJP leaders in Jantar Mantar protest case

6 minutes ago
Sensex, Nifty open lower as Asian markets tumble, crude oil climbs

23 minutes ago
Electricians attacked with sticks following altercation in Shamshabad

35 minutes ago
Man stripped, tonsured over car rental dispute in Golconda; five held

45 minutes ago
Property dispute turns violent as man allegedly bites sister-in-law in Film Nagar

55 minutes ago
TGSRTC Employees’ Union wins recognised union polls with 18,276 votes

1 hour ago
Every penny is accounted for, says Poonam Dhillon amid CINTAA fund row

1 hour ago
India slams UN rapporteur for falsely projecting Dawood Ibrahim as ‘India-based’

2 hours ago